Benzgalantamine Delayed Release Oral Tablet [Zunveyl]
RxNorm 2690637

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 2690637 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: benzgalantamine Delayed Release Oral Tablet [Zunveyl].

The following semantic concepts and normalized strings are associated with this clinical entity:

SBDF
Benzgalantamine Delayed Release Oral Tablet [Zunveyl]
AUI:12908028
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SBDFPrescribable

Semantic Branded Drug Form (SBDF):
Benzgalantamine Delayed Release Oral Tablet [Zunveyl]
(Atom ID: 12908028)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
benzgalantamine Delayed Release Oral Tablet [Zunveyl]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2690637
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12908028
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SBDF
Semantic Branded Drug Form (Ingredient + Dose Form + Brand Name)
Source Code
2690637
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Patient Education

Benzgalantamine


Benzgalantamine is used to treat the symptoms of Alzheimer's disease (AD; a brain disease that slowly destroys the memory and the ability to think, learn, communicate and handle daily activities). Benzgalantamine is in a class of medications called acetylcholinesterase inhibitors. It works by increasing the amount of a certain natural substance in the brain that is needed for memory and thought. Benzgalantamine may improve the ability to think and remember or slow the loss of these abilities in people who have AD. However, benzgalantamine will not cure AD or prevent the loss of mental abilities at some time in the future.
[Learn More]


* Please review the disclaimer below.